The s ix

Roman name

Factor IX P

The composition and the form of

The blood clotting IX. In one vial containing 300, 600 or 1,200 IU factor IX from human plasma, as well as heparin 100, 200 and 400 IU and antitrombin 2.5, 5 or 10 IU as a stabilizer

Of drugs

Provides specific hemostatic effect with hemophilia B (inheritance disease, as reflected increased krovotochivostyu), and other diseases associated with lack of a factor blood coagulability IX.

Storage conditions

In cool, the dark spot.

Indications for use

Prevention and treatment of bleeding in the treatment of hemophilia B, and other diseases caused by lack of factor IX.

Dosing and Administration

Dose selected depending on the degree of deficiency factor IX, as well as the size and location of bleeding. • Number of factor IX is determined as follows : when the ME 1 per 1 kg of body mass index level of factor IX more about \% rule. Preparation throw in the attached solvent and injected slowly or in the form of investments.

Side-Effects

Rarely, allergic reactions, increased body temperature.

Form of

Dry substance intravenous in vials. one bottle contains liofilizirovannuu (clay by freezing vacuum) fraction of human plasma with an activity factor IX 300, 600 or 1,200 M E together with the solvent (water for injection 10, 20 or 30 ml, respectively).

Directory → Gematotropona funds → Coagulants (including factors such as blood clotting), gemostatiki → The s ix